Loading…
Back To Schedule
Thursday, June 18 • 5:00pm - 6:00pm
#517 OD: ON DEMAND - Getting Real About Data Sharing for Drug Development and Drug Safety: What COVID-19 is Teaching us About the Possibilities and How to Move From Anomaly to Precedent

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Forum
Level: Basic

A panel of distinguished leaders in healthcare, consumer advocacy, and regulated industry will discuss how COVID-19 has broken the paradigm for data sharing as it pertains to drug development and drug safety research – and take the audience through an exercise to define shared value to move forward with a renewed commitment to more open data sharing with public health at its core.

Learning Objectives

Recognize barriers to data sharing for the purposes of drug safety and pharmacovigilance; Identify shared goals across consumer, health system, government, and industry stakeholders; Outline a platform for the responsible and collaborative engagement in data sharing and linkage for the purpose of drug safety and pharmacovigilance.

Chair

Carla Rodriguez-Watson, PhD, MPH

Speaker

Panelist
Sarah Greene, MPH

Panelist
Carlos Garner, PhD

Panelist
Deven McGraw, JD, LLM, MPH



Speakers
avatar for Deven McGraw

Deven McGraw

Chief Regulatory Officer, Ciitizen
Deven McGraw is the Chief Regulatory Officer for Ciitizen, a consumer health technology start-up. Prior to joining Ciitizen, she directed U.S. health privacy and security through her roles as Deputy Director, Health Information Privacy at the HHS Office for Civil Rights (the office... Read More →
avatar for Carla Rodriguez-Watson

Carla Rodriguez-Watson

Scientific Director, IMEDS, The Reagan-Udall Foundation For the FDA
Dr. Carla Rodriguez-Watson is the Scientific Director of the Innovation in Medical Evidence Development and Surveillance (IMEDS) program at the Reagan-Udall Foundation for the FDA. The Foudation’s mission is to advance FDA’s mission to modernize product development, accelerate... Read More →
CG

Carlos Garner

Vice-President Global Regulatory Affairs, Eli Lilly and Company
Executive leader for North American regulatory affairs for Eli Lilly and Company. The organization is responsible for all US and Canadian human drugs and devices regulatory affairs, and global manufacturing regulatory affairs. Organization provides strategic and operational regulatory... Read More →
SG

Sarah Greene

Strategic Consultant and Advisor, Independent Consultant
Sarah Greene, MPH, is a strategy consultant, advising research organizations and health systems on effectively translating research evidence into improved care and patient experience. Most recently, she was the Executive Director of the Health Care Systems Research Network (HCSRN... Read More →


Thursday June 18, 2020 5:00pm - 6:00pm
TBD Virtual Event Horsham, PA 19044